Search

everythinglearnresearchcommunity

for

Search:↓

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

p63 is essential for controlling epithelial stem cells and tissue health.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

HIV can cause unusual and severe skin problems that are hard to treat.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

New treatments for acne scars are safer and more effective because we understand the causes better.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Injecting a special gel with human protein particles can help hair grow.

High levels of androgens during early development may cause PCOS-like symptoms.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Male skin gets drier and more alkaline as it ages, which may need different skincare than women's skin.

FA2H is essential for normal fur and sebum production in mice.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Transdermal drug delivery systems are effective and promising for future use.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.